Author | Jonathan Strosberg, MD | OncLive

Author | Jonathan Strosberg, MD

Articles

Dr. Strosberg Discusses Updates From the NETTER-1 Study

November 09, 2018

Video

Jonathan Strosberg, MD, associate professor, Moffitt Cancer Center, discusses updates from the NETTER-1 study in patients with neuroendocrine tumors (NETs).

Dr. Strosberg on FDA Approval of Lutathera for GEP-NETs

January 26, 2018

Video

Jonathan Strosberg, MD, associate professor, Moffitt Cancer Center, discusses the FDA approval of Lutathera (177Lutetium DOTA-octreotate) as a treatment for patients with gastroenteropancreatic neuroendocrine tumors (GEP-NETs).

Dr. Strosberg on Quality of Life for Midgut Neuroendocrine Tumors

January 25, 2017

Video

Jonathan Strosberg, MD, medical oncologist, Department of Gastrointestinal Oncology, section head, Neuroendocrine Division, chair, Gastrointestinal Department Research Program, Moffitt Cancer Center, discusses quality of life in patients with midgut neuroendocrine tumors (NETs).

Dr. Strosberg on the Results of the NETTER-1 Trial

September 08, 2016

Article

Jonathan Strosberg, MD, associate professor, Moffitt Cancer Center, discusses the results of the NETTER-1 trial.

x